Morton Brown Family Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432 Buy
+2
New +$383 ﹤0.01% 391
2022
Q3
– Sell
-2
Closed – – 218
2022
Q2
$0 Buy
+2
New +$409 ﹤0.01% 270

Other funds holding BIIB

Morton Brown Family Wealth's BIIB Position: Q2 2026 in Review

Morton Brown Family Wealth opened a new position in Biogen (BIIB) in Q2 2026: 2 shares worth $432. The stake represents ﹤0.01% of the portfolio and ranks #391 among its holdings. This is a return to the name: Morton Brown Family Wealth previously reported a position in BIIB as recently as Q2 2022.

Morton Brown Family Wealth first reported a position in BIIB in Q2 2022 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Morton Brown Family Wealth held 2 shares of Biogen worth $432 as of Q2 2026.
  • Biogen was a new Morton Brown Family Wealth position in Q2 2026.
  • Biogen made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #391 holding.
  • Morton Brown Family Wealth first reported a position in Biogen in Q2 2022 and has held it in 2 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.